Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.7750
+0.1500 (24.00%)
Oct 10, 2025, 5:08 PM GMT+1
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 11.73 million as of October 10, 2025. Its market cap has decreased by -28.36% in one year.
Market Cap
11.73M
Enterprise Value
11.59M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.78
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 11.73M, a decrease of -77.33%. That is a compound annual growth rate of -25.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 11.73M | 24.79% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | 82.92M | 60.27% |
| Nov 3, 2020 | 51.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.21B |
| GSK plc | 65.38B |
| Haleon | 30.16B |
| Smith & Nephew | 11.23B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.02B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.68B |